EUVIMEDEUVIMED entdecken
Crossref

Is it the reconstruction or the complication? Factors associated with time to adjuvant chemotherapy after breast cancer surgery

Hasan Güç, Zeynep Gülsüm Güç, Hüseyin Döngelli, Cenk Demirdöver

European Journal of Surgical Oncology · 2027-01 · 53 (1) · 112355

DOI: 10.1016/j.ejso.2026.112355 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Surgical Oncology, 2027-01. Verfasst von Hasan Güç und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic, Reconstructive and Aesthetic Surgery, University of Health Sciences, Tepecik Training and Research Hospital, İzmir, Türkiye. E…. Die Arbeit nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Breast reconstruction may delay adjuvant chemotherapy, but whether delays are driven by reconstruction itself or by postoperative complications is unclear. MATERIALS AND METHODS: This two-centre retrospective cohort study included 187 patients who received adjuvant chemotherapy after breast cancer surgery between January 2019 and June 2024. Delay was defined as initiation more than 42 days after surgery. Multivariable logistic regression evaluated reconstruction status, surgical approach, reconstruction method and Clavien-Dindo complication severity; time to chemotherapy was also analysed as a continuous outcome. Firth regression, bootstrap resampling and sensitivity analyses assessed robustness. RESULTS: Mean time to chemotherapy was 39.6 ± 12.8 days; 72 patients (38.5%) started after 42 days and none after 90 days. Reconstruction (aOR 4.42, 95% CI 2.10-9.32) and complications (aOR 3.13, 95% CI 1.45-6.75) were independently associated with delay, lengthening the interval by an adjusted 8.8 and 8.2 days, respectively. Risk was highest after autologous or combined reconstruction (aOR 5.92, 95% CI 2.14-16.39) and Clavien-Dindo grade III complications (Firth aOR 7.27, 95% CI 2.26-29.95), whereas grade I-II complications were not associated with delay. Findings were consistent in patients who underwent mastectomy only (reconstruction aOR 3.33, 95% CI 1.32-8.44). CONCLUSION: Both reconstruction and, particularly, complications requiring reintervention were associated with a modest delay in adjuvant chemotherapy that remained within the interval regarded as oncologically safe. Preventing severe complications may allow patients to benefit from reconstruction without compromising timely systemic therapy.

Schlagwörter

Stichwörter der Autor:innen

AdjuvantBreast neoplasmsChemotherapyClavien–Dindo classificationMammaplastyPostoperative complicationsTime-to-treatment

Autor:innen und Institutionen

  • Department of Plastic, Reconstructive and Aesthetic Surgery, University of Health Sciences, Tepecik Training and Research Hospital, İzmir, Türkiye. Electronic address: drhasanguc@gmail.com.
  • Department of Medical Oncology, Atatürk Training and Research Hospital, İzmir Kâtip Çelebi University, İzmir, Türkiye.
  • Department of Internal Medicine, Dokuz Eylül University Faculty of Medicine, İzmir, Türkiye.
  • Private Practice in Plastic, Reconstructive and Aesthetic Surgery, İzmir, Türkiye.

Zitieren

APA

Güç, H., Güç, Z. G., Döngelli, H., & Demirdöver, C. (2027). Is it the reconstruction or the complication? Factors associated with time to adjuvant chemotherapy after breast cancer surgery. European Journal of Surgical Oncology, 53(1), 112355. https://doi.org/10.1016/j.ejso.2026.112355

Vancouver

Güç H, Güç ZG, Döngelli H, Demirdöver C. Is it the reconstruction or the complication? Factors associated with time to adjuvant chemotherapy after breast cancer surgery. European Journal of Surgical Oncology. 2027;53(1):112355. doi:10.1016/j.ejso.2026.112355

BibTeX
@article{G2027,
  author = {Güç, Hasan and Güç, Zeynep Gülsüm and Döngelli, Hüseyin and Demirdöver, Cenk},
  title = {Is it the reconstruction or the complication? Factors associated with time to adjuvant chemotherapy after breast cancer surgery},
  journal = {European Journal of Surgical Oncology},
  year = {2027},
  volume = {53},
  number = {1},
  pages = {112355},
  doi = {10.1016/j.ejso.2026.112355}
}
Kostenlos starten →